Monday, May 10, 2021

Monthly Archives: July 2011

Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline

Today Hawthorne, NY-based Acorda Therapeutics (NASDAQ: ACOR) announced that it licensed an experimental compound to treat spinal cord injury from medical-device giant Medtronic (NYSE: MDT). Acorda paid $3 million up front for worldwide rights...